Eli Lilly puts faith in drug pipeline
Eli Lilly and Co. started to tip over its massive “patent cliff” this year, yet announced little publicly that will significantly soften its inevitable sales plunge.
Patent
Articles
Hillenbrand wins ban of knockoff coffins from Mexico
The U.S. International Trade Commission said Monday that Ataudes Aguilares will be barred from bringing in caskets with attached memorabilia compartments, which Batesville-based Hillenbrand has patented.
Phase 10 inventor folds in dispute over top-selling card game
The inventor of the world's second-best-selling card game has settled a lawsuit with Fundex Games, the Plainfield company that markets and distributes Phase 10.
Lilly scores series of small victories
The Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
Court upholds Lilly patent on cancer drug Alimta
A U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of patent expirations in coming years.
Appeals court rejects Lilly over Gemzar patent
Without an appeal, generic drugs are now poised to wipe away most of Lilly’s $750 million in annual U.S. revenue from Gemzar.
Appeals court ruling upholds Lilly’s Evista patents
Eli Lilly and Co. won a court ruling Wednesday that blocks plans by Teva Pharmaceutical Industries Ltd. to sell a generic version of the Evista osteoporosis treatment before March 2014.
Eli Lilly loses patent lawsuit for Strattera
Eli Lilly and Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention
deficit hyperactivity drug Strattera. The patent had been set to expire in May 2017. Lilly plans to appeal.
Lilly braces for plunge in profits
Indianapolis-based drugmaker Eli Lilly and Co. faces such an unprecedented string of patent expirations and an unheard-of
loss of revenue that it’s hard to picture what the company will look like in five years.
Roche hit with new breed of patent suit
Roche Diagnostics, a Swiss company that keeps its U.S. headquarters in Indianapolis, has been sued for marking its Accu-Chek
blood glucose monitors and accessories with patents that are expired. Illinois resident David O’Neill has sued on behalf
of the U.S. government to recover damages of $500 per infraction.
Court defeat lost in Lilly’s gloomy long-term outlook
Eli Lilly and Co.’s loss of a patent on one of its blockbuster drugs in court late last month received a collective yawn
from
investors, who have shunned the stock because of five looming patent expirations.
Hoosier firms that rely on innovation pine for patent reform
One key change would grant patents to the first inventor to file an application, not the first who can prove to have made
the invention first.
Hillenbrand unit seeks to block imports of knockoff coffins
Hillenbrand Inc.’s Batesville unit, the largest U.S. maker of coffins,wants the trade commission to prevent Ataudes Aguilares
from selling its products in the United States and Puerto Rico.
Lilly sues to block copy of Evista osteoporosis drug
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
Anderson tech firm One Number files patent suit against Google
An Anderson firm that provides a “one number” service that rings all of a client’s phones has filed suit
against Web giant Google, alleging Google Voice infringes on two of its patents.
Noblesville company has high hopes for pomegranate
Verdure Sciences, a botanical-extract distributor, has invested more than $1 million in marketing and research,
and hopes to see its product in more
foods and drinks, perhaps even mouthwash.
Local attorney sues Fundex over game royalties
A local lawyer who created the game “Chronology” alleges breach of contract, trademark infringement, use of a counterfeit
mark, unfair competition, copyright infringement, trademark dilution and forgery.
Lilly sues to block generic of Adcirca lung treatment
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
Intellectual property practices in law firms recovering from recession
Practices are beginning to thaw along with other areas of the economy.
Pfizer’s Viagra patent partially rejected in Lilly fight
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn’t different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.